The Zacks Analyst Blog Highlights Eli Lilly, Sanofi Merck, AstraZeneca's and Roche
Chicago, IL – July 8, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity ...
WISH-TV24m
Lilly to acquire biopharmaceutical company Morphic; aims to improve results for IBD patients
Eli Lilly and Company announced Monday morning that it has reached an agreement to acquire biopharmaceutical company Morphic.
Lilly To Acquire Morphic In Approx. $3.2 Bln Deal - Quick Facts
Eli Lilly and Company (LLY) and Morphic Holding (MORF) announced a definitive agreement for Lilly to acquire Morphic, a ...
Ibj.com18m
Lilly to buy Massachusetts biopharma company for $3.2B
Massachusetts-based Morphic Holding Inc. is a nine-year old, publicly traded company that is developing a class of drugs known as oral integrin therapies to treat autoimmune diseases, pulmonary ...
Lilly to Buy US Biotech Morphic in $3.2 Billion Deal (Correct)
Eli Lilly & Co. agreed to buy U.S. biopharma company Morphic Holding Inc. for about $3.2 billion to gain experimental therapies for inflammatory bowel disease and other chronic illnesses.
Eli Lilly Remains an Equities Outlier
New obesity and Alzheimer’s disease treatments are keeping Eli Lilly and Company (LLY) at the forefront of equities ...
Eli Lilly & Co. stock outperforms competitors on strong trading day
Shares of Eli Lilly & Co. LLY rallied 1.83% to $914.57 Friday, on what proved to be an all-around positive trading session ...
FDA approves new Alzheimer's treatment, donanemab from Eli Lilly
Branded as Kisunla by drugmaker Eli Lilly, donanemab's approval follows years of setbacks and delays in getting the ...
Mounjaro and Zepbound Are Great, but This Is the Real Reason Why Eli Lilly Can Soar Past a $1 Trillion Valuation
Investors shouldn't assume that all of the company's future growth is already priced into the stock's valuation.